Merck & Co. Inc. / Policy Food / Drug Administration THROUGH / Policy Hypertension / Behavioral Cardiovascular Health / /
Currency
USD / /
Facility
Columbia University College of Physicians / Mount Sinai Medical Center / /
IndustryTerm
coronary artery disease prevention / cardiovascular disease prevention / prevention of heart disease / competing products / human drug products / treatment of a broad spectrum of human symptoms / marketed and investigational human drug products / coronary heart disease prevention / treatment of endocrine and metabolic disorders / drug products / /
Consultants Staff Center for Drug Evaluation / American Psychosomatic Society / Endocrinologic and Metabolic Drugs Advisory Committee / Management Staff office of Policy / Mount Sinai Medical Center / Food and Drug Administration / Metabolic Drugs Advisory Committee / Columbia University College of Physicians and Surgeons / Academy of Behavioral Medicine Research / Task Force on Behavioral Medicine of the National Heart / Lung / and Blood Institute &d / Nonprescription Drugs Advisory Committee / DEPARTMENT OF HEALTH / /s/ Vince Tolino Director / Ethics and Integrity Staff office of Management Programs office of Management Michael F. Ortwerth / Advisory Board / Society of Behavioral Medicine / American Society of Hypertension / /
Person
Igor Cerny / Randall W. Lutter / Michael F. Ortwerth / Behavioral Cardiovascular / Thomas Pickering / Drug Administratir Rockville / Vince Tolino / /
Position
cardiologist / President / Director / Deputy Commissioner for Policy / Commissioner / appointing official / Deputy Director / Advisory Committee / physician / Director / Advisors / Deputy Commissioner / member / /
(4 ".,a r*rnQ. DEPARTMENT OF HEALTH dk HUMAN SERVICES